NCT04531332 is a NA clinical trial of Continuous infusion Linezolid in Pneumonia, sponsored by October 6 University.

Who is sponsoring NCT04531332?

NCT04531332 is sponsored by October 6 University.

What drugs are being tested in NCT04531332?

Interventions in NCT04531332: Continuous infusion Linezolid, intermittent dosing linezolid.

Is NCT04531332 still recruiting?

NCT04531332 is currently status unknown. Last updated 16 September 2021.

Last reviewed 2021-09-16 · How we verify

NCT04531332

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Continuous Infusion of Linezolid Versus Intermittent Dosing in the Treatment of Nosocomial Pneumonia

Status unknown NA Last updated 16 September 2021

What this trial tests

NA trial testing Continuous infusion Linezolid in Pneumonia in 169 participants. Status unknown.

Timeline

15 November 2019

Primary endpoint
15 September 2021

15 September 2021

Quick facts

Lead sponsor	October 6 University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	169
Start date	15 November 2019
Primary completion	15 September 2021
Estimated completion	15 September 2021
Sites	1 location across Egypt

Drugs / interventions tested

Continuous infusion Linezolid — full drug profile →
intermittent dosing linezolid — full drug profile →

Conditions studied

Pneumonia — all drugs for Pneumonia →

Sponsor

October 6 University

Who can join

Adults 18 to 80, any sex, with Pneumonia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigator's goal in this study is to determine the clinical efficacy and safety of continuous infusion in comparison with standard intermittent infusion.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Continuous Versus Intermittent Linezolid Infusion for Critically Ill Patients with Hospital-Acquired and Ventilator-Associated Pneumonia: Efficacy and Safety Challenges.
Abou Warda AE, Sarhan RM, Al-Fishawy HS, Moharram AN, et al · · 2022 · cited 9× · PMID 35337094 · DOI 10.3390/ph15030296

Verify or expand the search:

Other recruiting trials for Pneumonia

Currently open trials in the same condition.

NCT07453966 — Efficacy and Safety of Intrapulmonary Percussive Ventilation in Patients With Pulmonary Infection Receiving Invasive Mec · NA · recruiting
NCT07251465 — A Study to Learn How Effective is PCV20 to Help Stop Adults Who Have a Higher Chance of Getting Pneumonia · active not recruiting
NCT07311343 — Oral Hygiene and Prophylactic Antibiotics to Prevent Intracerebral Hemorrhage Associated Pneumonia · Phase 4 · recruiting
NCT07298889 — High PEEP in Noninvasive Ventilation Patients With Pneumonia or ARDS · NA · recruiting
NCT06911658 — Infectious Complications After Esophagectomy · recruiting

Other October 6 University trials

Trials by the same sponsor.

NCT07235072 — Passive Fit and Time Efficiency in All On-X Implants Protocols Using Photogrammetry, Splinted Scan Bodies, and Conventio · NA · not yet recruiting
NCT07403851 — Effect of Scanning Technology on the Accuracy of Digitally Customized Intraradicular Attachments · NA · not yet recruiting
NCT07305792 — High Tone Power Therapy on Lumbosacral Radiculopathy Patients · NA · completed
NCT07132736 — Impact of Underwater Exercise Versus Regular Aerobic Exercise on Quality of Life and Power of Muscle · NA · recruiting
NCT07350655 — Efficacy of Virtual Reality-based Training in Patients With Chronic Non-specific Low Back Pain · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04531332 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by October 6 University
Last refreshed: 16 September 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04531332.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing